These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13952652)

  • 1. Studies on dopa decarboxylase inhibitors in vivo by use of C14-carboxyl-labeled dopa.
    HANSSON E; CLARK WG
    Proc Soc Exp Biol Med; 1962 Dec; 111():793-8. PubMed ID: 13952652
    [No Abstract]   [Full Text] [Related]  

  • 2. [Action of some DOPA decarboxylase inhibitors with reference to different types of convulsions].
    HEROLD M; CAHN J; HELBECQUE C; KABACOFF O
    C R Seances Soc Biol Fil; 1962; 156():1273-6. PubMed ID: 13954030
    [No Abstract]   [Full Text] [Related]  

  • 3. Coenzyme--substrate adducts as inhibitors of mouse liver 3,4-dihydroxyphenylalanine decarboxylase.
    Rudd EA; Cunningham WC; Thanassi JW
    J Med Chem; 1979 Mar; 22(3):233-7. PubMed ID: 423204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DOPA decarboxylase inhibition through the interaction of coenzyme and substrate.
    SCHOTT HF; CLARK WG
    J Biol Chem; 1952 May; 196(1):449-62. PubMed ID: 12980987
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity.
    Tran N
    Experientia; 1972 Sep; 28(9):1021-2. PubMed ID: 4665286
    [No Abstract]   [Full Text] [Related]  

  • 7. The enzymatic decarboxylation of DOPA in human liver homogenates.
    Vogel WH; Snyder R; Hare TA
    Proc Soc Exp Biol Med; 1970 Jun; 134(2):477-81. PubMed ID: 5310151
    [No Abstract]   [Full Text] [Related]  

  • 8. New pathway for metabolism of dopa.
    O'Leary MH; Baughn RL
    Nature; 1975 Jan; 253(5486):52-3. PubMed ID: 1167399
    [No Abstract]   [Full Text] [Related]  

  • 9. Microdialysis monitoring of 3,4-dihydroxyphenylalanine accumulation after decarboxylase inhibition: a means to estimate in vivo changes in tyrosine hydroxylase activity of the rat locus ceruleus.
    Robert F; Lambás-Señas L; Ortemann C; Pujol JF; Renaud B
    J Neurochem; 1993 Feb; 60(2):721-9. PubMed ID: 8093483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
    Yamabe H; Lovenberg W
    Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
    [No Abstract]   [Full Text] [Related]  

  • 11. How does L-dopa work in parkinsonism?
    Sandler M
    Lancet; 1971 Apr; 1(7703):784. PubMed ID: 4101278
    [No Abstract]   [Full Text] [Related]  

  • 12. Limited tryptic proteolysis of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Simmaco M; Schininà ME; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1988 Feb; 260(2):569-76. PubMed ID: 3124758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aromatic L-amino acid decarboxylase by coenzyme-amino acid adducts.
    Rudd EA; Thanassi JW
    Biochemistry; 1981 Dec; 20(26):7469-75. PubMed ID: 7326239
    [No Abstract]   [Full Text] [Related]  

  • 14. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
    Gauthier G; Juge O; Birchler A
    Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
    [No Abstract]   [Full Text] [Related]  

  • 15. Accurate assay of dopa decarboxylase by preventing nonenzymatic decarboxylation of dopa.
    Okuno S; Fujisawa H
    Anal Biochem; 1983 Mar; 129(2):412-5. PubMed ID: 6405659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 18. An essential arginine residue at the binding site of pig kidney 3,4-dihydroxyphenylalanine decarboxylase.
    Tancini B; Dominici P; Barra D; Voltattorni CB
    Arch Biochem Biophys; 1985 May; 238(2):565-73. PubMed ID: 3994391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions of DOPA (3,4-dihydroxyphenylalanine) decarboxylase with DOPA.
    Minelli A; Charteris AT; Voltattorni CB; John RA
    Biochem J; 1979 Nov; 183(2):361-8. PubMed ID: 534502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INDUCTION OF DOPA-DECARBOXYLASE ACTIVITY BY INSECT MESSENGER RNA IN AN IN VITRO AMINO ACID INCORPORATING SYSTEM FROM RAT LIVER.
    SEKERIS CE; LANG N
    Life Sci (1962); 1964 Jun; 3():625-32. PubMed ID: 14187505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.